Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (111-120 of 350) with videos related to

Pageof 35
Sort By:
Acta Neuropathologica|January 27, 2018
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)David N Louis, Pieter Wesseling, Werner Paulus, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Brain Pathology (Zurich, Switzerland)|October 8, 2015
Genetic Alterations in Gliosarcoma and Giant Cell GlioblastomaJi Eun Oh, Takashi Ohta, Naosuke Nonoguchi, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
BMC Medicine|October 27, 2016
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zoneChristine Jungk, Andreas Mock, Janina Exner, et al.
Blood|August 4, 2012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosisFelix Sahm, David Capper, Matthias Preusser, et al.
Acta Neuropathologica|March 19, 2020
Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomasFranz L Ricklefs, Krystian D Fita, Roman Rotermund, et al.
Brain Pathology (Zurich, Switzerland)|December 19, 2013
BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expressionChristian Koelsche, Felix Sahm, Adelheid Wöhrer, et al.
Acta Neuropathologica|October 21, 2011
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesDavid Capper, Anna Sophie Berghoff, Manuel Magerle, et al.
Investigational New Drugs|March 7, 2020
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant gliomaAntje Wick, Annick Desjardins, Cristina Suarez, et al.
Pageof 35

Showing results (111-120 of 350) with videos related to

Sort By:
Pageof 35
Acta Neuropathologica|January 27, 2018
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)David N Louis, Pieter Wesseling, Werner Paulus, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Brain Pathology (Zurich, Switzerland)|October 8, 2015
Genetic Alterations in Gliosarcoma and Giant Cell GlioblastomaJi Eun Oh, Takashi Ohta, Naosuke Nonoguchi, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
BMC Medicine|October 27, 2016
Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zoneChristine Jungk, Andreas Mock, Janina Exner, et al.
Blood|August 4, 2012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosisFelix Sahm, David Capper, Matthias Preusser, et al.
Acta Neuropathologica|March 19, 2020
Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomasFranz L Ricklefs, Krystian D Fita, Roman Rotermund, et al.
Brain Pathology (Zurich, Switzerland)|December 19, 2013
BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expressionChristian Koelsche, Felix Sahm, Adelheid Wöhrer, et al.
Acta Neuropathologica|October 21, 2011
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesDavid Capper, Anna Sophie Berghoff, Manuel Magerle, et al.
Investigational New Drugs|March 7, 2020
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant gliomaAntje Wick, Annick Desjardins, Cristina Suarez, et al.
Pageof 35